Research
Innovative collaboration leads to new insights into TB immune response
AHRI celebrates two new PhD graduates
Covid-19 variant 501Y.V2 is cross protective
TB research must continue in the face of the Covid-19 pandemic
First ever national survey shows the extent of South Africa’s TB problem
TB research in the time of Covid-19: mini-symposium
FEATURED ARTICLE
Health systems readiness for the UNAIDS ‘95’ targets in rural KwaZulu-Natal
Covid-19 variant 501Y.V2 may be cross protective
New Covid-19 501Y.V2 variant escapes antibodies
What scientists know about the 501Y.V2 variant
Scientists identify warning signs over effectiveness of dolutegravir in sub-Saharan Africa
KZN Covid-19 Research Consortium Virtual Conference
